Trademark: 88365991
Word
Q-CARD
Status
Registered
Status Code
700
Status Date
Tuesday, November 8, 2022
Serial Number
88365991
Registration Number
6895554
Registration Date
Tuesday, November 8, 2022
Mark Type
4000
Filing Date
Monday, April 1, 2019
Published for Opposition
Tuesday, January 14, 2020

Trademark Owner History
Essenlix Corporation - Original Registrant

Classifications
5 Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases
1 Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, or diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use
44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing in the nature of the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases, diagnostic testing, namely, medical testing for diagnostic purposes, and wellness services, namely, providing wellness information in the fields of health and wellness, all of the foregoing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes
10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes
42 Scientific laboratory services, namely, detection and identification of cells, proteins, small molecules, and nucleotides in a sample for scientific, research, and technological purposes; Medical laboratory services, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of infectious and residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; Development of new technology for others in the fields of biotechnology, DNA, RNA, small molecules, proteins, and nucleotide analysis services for scientific research purposes; Providing medical and scientific research information in the field of clinical trials, assays and assay development, diagnostics, cancer, RNA, DNA, small molecules, proteins, and nucleotides; Research and development in the medical and digital diagnostics and biotechnology fields; Custom design and development of chemical reagents and biochemical assays; Laboratory research in the field of oncology, hematology, and infectious diseases

Trademark Events
Nov 8, 2022
Notice Of Registration Confirmation Emailed
Nov 8, 2022
Registered-Principal Register
Oct 1, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 30, 2022
Allowed Principal Register - Sou Accepted
Sep 23, 2022
Statement Of Use Processing Complete
Sep 12, 2022
Use Amendment Filed
Sep 23, 2022
Case Assigned To Intent To Use Paralegal
Sep 12, 2022
Teas Statement Of Use Received
Mar 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 10, 2022
Sou Extension 4 Granted
Mar 10, 2022
Sou Extension 4 Filed
Mar 10, 2022
Teas Extension Received
Sep 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 9, 2021
Sou Extension 3 Granted
Sep 9, 2021
Sou Extension 3 Filed
Sep 9, 2021
Teas Extension Received
Mar 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2021
Sou Extension 2 Granted
Mar 1, 2021
Sou Extension 2 Filed
Mar 1, 2021
Teas Extension Received
Sep 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2020
Sou Extension 1 Granted
Sep 1, 2020
Sou Extension 1 Filed
Sep 1, 2020
Teas Extension Received
Mar 10, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 14, 2020
Published For Opposition
Dec 25, 2019
Notification Of Notice Of Publication E-Mailed
Dec 10, 2019
Approved For Pub - Principal Register
Dec 10, 2019
Examiner's Amendment Entered
Dec 10, 2019
Notification Of Examiners Amendment E-Mailed
Dec 10, 2019
Examiners Amendment E-Mailed
Dec 10, 2019
Examiners Amendment -Written
Jun 13, 2019
Notification Of Non-Final Action E-Mailed
Jun 13, 2019
Non-Final Action E-Mailed
Jun 13, 2019
Non-Final Action Written
Jun 11, 2019
Assigned To Examiner
Apr 19, 2019
New Application Office Supplied Data Entered In Tram
Apr 4, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24